Tirzepatide has emerged as a novel new option for individuals with type 2 diabetes. This groundbreaking medication combines the actions of two agents, GLP-1 and GIP, to effectively lower blood sugar levels. Early https://bookmarkcolumn.com/story20289035/tirzepatide-a-breakthrough-in-diabetes-treatment